Search results
Results from the WOW.Com Content Network
Pfizer UK (officially Pfizer Ltd) is the principal subsidiary of the multinational pharmaceutical company Pfizer in the United Kingdom.. Pfizer UK has its business headquarters in Tadworth, Surrey, major offices in Maidenhead, Berkshire, research and development facilities in Cambridge, Cambridgeshire and Sandwich, Kent, and a manufacturing and distribution site in Havant, Hampshire.
ViiV Healthcare. ViiV Healthcare ( / ˈviːv / VEEV) is a British multinational pharmaceutical company specializing in the research and development of medicines to treat and prevent HIV/AIDS. Its global headquarters is located in London. The company was created as a joint venture by GSK and Pfizer in November 2009, with both companies ...
LEO – LEO Pharma. LifeScan – LifeScan. Lilly – Eli Lilly and Company Ltd. Lundbeck – Lundbeck Ltd. Martindale Pharma – Martindale Pharmaceuticals - Ltd (Now Ethypharm UK) Mölnlycke – Mölnlycke Health Care Ltd. Mayne – Mayne Pharma plc. McNeil – McNeil Laboratories Ltd. Meda – Meda Pharmaceuticals Ltd.
The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. [1] [2] In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical ...
It now expects earnings per share between $2.15 and $2.35. That's up from previous guidance of between $2.05 and $2.25. The company's dividend is $0.42 per share quarterly, or $1.68 annually. It's ...
But two hours before the closing bell rang in the weekend, a flurry of selling began, driving the Dow Jones Industrial Average down 208 points, or 1.4%, to end at 15,115. Pfizer Stock Slumps, Dow ...
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Here are three reasons investors should consider snapping up Pfizer as a long-term investment with market-beating potential. 1. This 6% dividend yield is no trap. Pfizer has long been a dividend ...